CD8A and neoplasm: Treatment with the inhibitors notably augmented T cell tumor infiltration, augmented the activation of CD8+ T cells via ATP, and induced the formation of tumor‐associated PD‐1+ TCF1+ CD8+ CD4+ stem‐like DPT cells.